These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22930888)

  • 21. Systemic metabolic radiotherapy with samarium-153 EDTMP for the treatment of painful bone metastasis.
    Serafini AN
    Q J Nucl Med; 2001 Mar; 45(1):91-9. PubMed ID: 11456381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unsealed source therapy of painful bone metastases: an update.
    McEwan AJ
    Semin Nucl Med; 1997 Apr; 27(2):165-82. PubMed ID: 9144858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer: preliminary report of a multicenter trial. UK Metastron Investigators Group.
    Bolger JJ; Dearnaley DP; Kirk D; Lewington VJ; Mason MD; Quilty PM; Reed NS; Russell JM; Yardley J
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):32-3. PubMed ID: 7684863
    [No Abstract]   [Full Text] [Related]  

  • 24. [Radionuclide therapy for the treatment of skeletal metastases of urological malignancies: a forgotten therapy?].
    Badawi JK
    Dtsch Med Wochenschr; 2012 Aug; 137(33):1645-9. PubMed ID: 22875692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nationally produced 153SmEDTMP in the palliative treatment of metastatic bone cancer pain].
    Olea E; Gil MC; Tomicic M; Araya G; Chandía M; Quintana JC; Pinto L; Orellana P; Nagel J; Ortíz V
    Rev Med Chil; 1996 Jul; 124(7):805-12. PubMed ID: 9138368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review.
    Jong JM; Oprea-Lager DE; Hooft L; de Klerk JM; Bloemendal HJ; Verheul HM; Hoekstra OS; van den Eertwegh AJ
    Eur Urol; 2016 Sep; 70(3):416-26. PubMed ID: 26391636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases.
    Resche I; Chatal JF; Pecking A; Ell P; Duchesne G; Rubens R; Fogelman I; Houston S; Fauser A; Fischer M; Wilkins D
    Eur J Cancer; 1997 Sep; 33(10):1583-91. PubMed ID: 9389919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strontium 89 in the treatment of bony metastases.
    Porter AT; Ben-Josef E
    Important Adv Oncol; 1995; ():87-94. PubMed ID: 7545646
    [No Abstract]   [Full Text] [Related]  

  • 29. 89Sr versus 153Sm-EDTMP: comparison of treatment efficacy of painful bone metastases in prostate and breast carcinoma.
    Baczyk M; Czepczyński R; Milecki P; Pisarek M; Oleksa R; Sowiński J
    Nucl Med Commun; 2007 Apr; 28(4):245-50. PubMed ID: 17325585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Samarium-153 ethylenediamine tetramethylene phosphonate therapy for bone pain palliation in skeletal metastases.
    Tripathi M; Singhal T; Chandrasekhar N; Kumar P; Bal C; Jhulka PK; Bandopadhyaya G; Malhotra A
    Indian J Cancer; 2006; 43(2):86-92. PubMed ID: 16790946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Palliative radiotherapy for metastatic bone tumor].
    Yoshida K; Hiratsuka J
    Clin Calcium; 2006 Apr; 16(4):641- 45. PubMed ID: 16582516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Samarium-153-lexidronam therapy for metastatic bone pain.
    Ribera H
    J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):80-1; discussion 81-2. PubMed ID: 23527672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative analysis of patients not responding to a single dose of 153Sm-EDTMP palliative treatment for painful skeletal metastases.
    Tian J; Cao L; Zhang J; Ouyang Q; Hou Q; He Y
    Chin Med J (Engl); 2002 Jun; 115(6):824-8. PubMed ID: 12123545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer.
    Quilty PM; Kirk D; Bolger JJ; Dearnaley DP; Lewington VJ; Mason MD; Reed NS; Russell JM; Yardley J
    Radiother Oncol; 1994 Apr; 31(1):33-40. PubMed ID: 7518932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective dosimetry with 99mTc-MDP in metabolic radiotherapy of bone metastases with 153Sm-EDTMP.
    Bianchi L; Baroli A; Marzoli L; Verusio C; Chiesa C; Pozzi L
    Eur J Nucl Med Mol Imaging; 2009 Jan; 36(1):122-9. PubMed ID: 18751975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [153Sm-EDTMP for moderate and severe bone cancer pain].
    Deng H; Luo S; Tan T; Mo T; Liang Z; Pu M; Jiao J; Zhong S; Wang Q; Hu Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Dec; 26(4):391-4. PubMed ID: 8732058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of samarium-153-EDTMP in disseminated skeletal metastases.
    Pusuwan P; Chaiwatanarat T; Chaudakshetrin P; Virawat N; Pattaranutaporn P; Chansilpa Y; Suntornpong N; Tocharoenchai C; Buranapong P; Chanachai R; Suputtamongkol Y; Pleehachinda R
    J Med Assoc Thai; 1996 Sep; 79(9):579-84. PubMed ID: 8996987
    [No Abstract]   [Full Text] [Related]  

  • 38. Samarium lexidronam (153Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma.
    Anderson P; Nuñez R
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1517-27. PubMed ID: 18020921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analgesic response and secondary effects in patients with osteoblastic metastasis, treated with Samarium 153 ethylenediaminotetramethylenephosphate].
    Lovera C; Massardo T; Galleguillos MC; González P; Comparini B; Yáñez M; Fodor M; Gil MC; Araya G; Tomicic M
    Rev Med Chil; 1998 Aug; 126(8):963-71. PubMed ID: 9830748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pain palliative therapy in women with breast cancer osseous metastatic disease and the role of specific serum cytokines as prognostic factors.
    Iakovou I; Doumas A; Badiavas K; Mpalaris V; Frangos S; Farmakis G
    Cancer Biother Radiopharm; 2014 Apr; 29(3):116-23. PubMed ID: 24392878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.